Citicoline as Neuroprotector in Neonates Exposed to Hypoxia

Phase 3

Recruiting

• Conditions: Neonatal Hypoxia
• Interventions: Other: Placebo; Drug: Citicoline

• Registration Number: NCT03949049
• Lead Sponsor: Sherief Abd-Elsalam

Brief Summary

Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial

Detailed Description

Efficacy of Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial

Study Timeline

• Study Start: 2019-02-01
• Status Verified: 2019-05
• Study First Submitted: 2019-05-11
• Study First Submitted QC: 2019-05-13
• Study First Posted: 2019-05-14
• Last Update Submitted: 2019-05-24
• Last Update Posted: 2019-05-29
• Primary Completion: 2029-12-01
• Study Completion: 2029-12-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• neonates with hypoxia.

Read More

Exclusion Criteria

• hypoxic ischemic encephalopathy

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Placebo	Placebo	Placebo
Citacoline	Citicoline	Citacoline as neuroprotector

Primary Outcome Measures

Name	Time	Method
number of seizures	6 months

Trial Locations

Locations (1)

Sherief Abd-Elsalam; 🇪🇬 Cairo, Egypt